ENDRA Life Sciences Inc. (NDRA)
NDRA Stock Price Chart
Explore ENDRA Life Sciences Inc. interactive price chart. Choose custom timeframes to analyze NDRA price movements and trends.
NDRA Company Profile
Discover essential business fundamentals and corporate details for ENDRA Life Sciences Inc. (NDRA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
30 Jun 2017
Employees
21.00
Website
https://www.endrainc.comCEO
Alexander Y. Tokman
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
NDRA Financial Timeline
Browse a chronological timeline of ENDRA Life Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Mar 2026
Upcoming earnings on 21 Nov 2025
EPS estimate is -$2.67.
Earnings released on 14 Aug 2025
EPS came in at -$1.71 surpassing the estimated -$2.27 by +24.67%.
Earnings released on 15 May 2025
EPS came in at -$2.59 surpassing the estimated -$3.91 by +33.76%.
Earnings released on 31 Mar 2025
EPS came in at -$9.40 falling short of the estimated -$4.10 by -129.27%, while revenue for the quarter reached $211.60K .
Earnings released on 15 Nov 2024
EPS came in at -$5.85 surpassing the estimated -$62.30 by +90.61%.
Stock split effective on 7 Nov 2024
Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 20 Aug 2024
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2024
EPS came in at -$139.86 falling short of the estimated -$0.07 by -199.70K%.
Earnings released on 14 May 2024
EPS came in at -$454.55 falling short of the estimated -$0.27 by -168.25K%.
Earnings released on 28 Mar 2024
EPS came in at -$297.20 falling short of the estimated -$0.36 by -82.46K%, while revenue for the quarter reached $428.41K .
Earnings released on 14 Nov 2023
EPS came in at -$699.30 falling short of the estimated -$0.43 by -162.53K%.
Earnings released on 14 Aug 2023
EPS came in at -$751.75 falling short of the estimated -$0.55 by -136.58K%.
Earnings released on 15 May 2023
EPS came in at -$1.63K surpassing the estimated -$1.78K by +8.82%.
Earnings released on 14 Mar 2023
EPS came in at -$1.82K falling short of the estimated -$1.40K by -30.00%.
Stock split effective on 9 Dec 2022
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$1.75K surpassing the estimated -$2.10K by +16.67%.
Earnings released on 15 Aug 2022
EPS came in at -$2.10K falling short of the estimated -$1.75K by -20.00%.
Earnings released on 12 May 2022
EPS came in at -$2.45K matching the estimated -$2.45K.
Earnings released on 30 Mar 2022
EPS came in at -$2.45K falling short of the estimated -$1.60 by -152.87K%.
Earnings released on 15 Nov 2021
EPS came in at -$2.10K surpassing the estimated -$2.45K by +14.29%.
Earnings released on 12 Aug 2021
EPS came in at -$2.80K falling short of the estimated -$2.45K by -14.29%.
Earnings released on 17 May 2021
EPS came in at -$2.10K surpassing the estimated -$2.45K by +14.29%.
Earnings released on 25 Mar 2021
EPS came in at -$3.50K surpassing the estimated -$4.90K by +28.57%.
Earnings released on 16 Nov 2020
EPS came in at -$5.24K surpassing the estimated -$5.59K by +6.25%.
NDRA Stock Performance
Access detailed NDRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.